[1] Aranda JV,Gorman W,Bergsteinsson H,et al.Efficacy of Caffeine in Treatment of Apnea in the Low-Birth-Weight Infant.J Pediatr,1977,90:467-472.
[2] 于梅,黄金华,朱蓉,等.枸橼酸咖啡因治疗对呼吸暂停早产儿早期肺功能的影响.中国当代儿科杂志,2016,18:206-210.
[3] Stark A,Smith PB,Hornik CP,et al.Medication Use in the Neonatal Intensive Care Unit and Changes from 2010 to 2018.J Pediatr,2022,240:66-71.
[4] Schmidt B,Doyle LW,Solimano A.Caffeine Therapy for Apnea of Prematurity.N Engl J Med,2006,354:2112-2121.
[5] Schmidt B,Ohlsson A.Long-Term Effects of Caffeine Therapy for Apnea of Prematurity.N Engl J Med,2007,357:1893-1902.
[6] Schmidt B,Anderson PJ,Doyle LW,et al.Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.JAMA,2012,307:275-282.
[7] Schmidt B,Roberts RS,Anderson PJ,et al.Academic Performance,Motor Function,and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity:An 11-Year Follow-Up of the Cap Randomized Clinical Trial.JAMA Pediatr,2017,171:e10.
[8] Kua KP,Lee SWH.Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates:systematic review of early caffeine therapy in preterm neonates.Br J Clin Pharmacol,2017,83:180-191.
[9] Eichenwald EC,Committee on Fetus and Newborn,American Academy of Pediatrics.Apnea of Prematurity.Pediatrics,2016,137:e20153757.
[10] Henderson-smart DJ,Davis PG.Prophylactic methylxanthines for endotracheal extubation in preterm infants.Cochrane Database Syst Rev,2010,8:CD000139.
[11] Cheong JLY,Doyle LW.Childhood respiratory outcomes after neonatal caffeine therapy.Semin Fetal Neonatal Med,2020,25:101158.
[12] Atik A,De Matteo R,Boomgardt M,et al.Impact of High-Dose Caffeine on the Preterm Ovine Cerebrum and Cerebellum.Front Physiol,2019,10:990.
[13] Liu S,Zhang X,Liu Y,et al.Early application of caffeine improves white matter development in very preterm infants.Respir Physiol Neurobiol,2020,281:103495.
[14] Dobson NR,Patel RM,Smith PB,et al.Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants.J Pediatr,2014,164:992-998.
[15] Elmowafi M,Mohsen N,Nour I,et al.Prophylactic versus therapeutic caffeine for apnea of prematurity:a randomized controlled trial.J Matern Fetal Neonatal Med,2021:1-9.
[16] Shenk EE,Bondi DS,Pellerite MM,et al.Evaluation of Timing And Dosing of Caffeine Citrate in Preterm Neonates for the Prevention of Bronchopulmonary Dysplasia.J Pediatr Pharmacol Ther,2018,23:139-145.
[17] Lodha A,Entz R,Synnes A,et al.Early Caffeine Administration and Neurodevelopmental Outcomes in Preterm Infants.Pediatrics,2019,143:e20181348.
[18] Borszewska-Kornacka MK,HoŻejowski R,Rutkowska M,et al.Shifting the boundaries for early caffeine initiation in neonatal practice:results of a prospective,multicenter study on very preterm infants with respiratory distress syndrome.PLoS One,2017,12:e0189152.
[19] Amaro CM,Bello JA,Jain D,et al.Early Caffeine and Weaning from Mechanical Ventilation in Preterm Infants:A Randomized,Placebo-Controlled Trial.J Pediatr,2018,196:52-57.
[20] Chen J,Jin L,Chen X.Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants:A Systematic Review and Meta-Analysis.BioMed Res Int,2018,2018:9061234.
[21] 张霄,张海涛,吕勇,等.不同维持剂量枸橼酸咖啡因治疗极低出生体重早产儿呼吸暂停的前瞻性随机对照研究.中国当代儿科杂志,2019,21:558-561.
[22] Vliegenthart R,Miedema M,Hutten GJ,et al.High versus standard dose caffeine for apnoea:a systematic review.Arch Dis Child Fetal Neonatal Ed,2018,103:F523-F529.
[23] Mohd Kori AM,Van Rostenberghe H,Ibrahim NR,et al.A Randomized Controlled Trial Comparing Two Doses of Caffeine for Apnoea in Prematurity.Int J Environ Res Public Health,2021,18:4509.
[24] Mcpherson C,Neil JJ,Tjoeng TH,et al.A pilot randomized trial of high-dose caffeine therapy in preterm infants.Pediatr Res,2015,78:198-204.
[25] Firman B,Molnar A,Gray PH.Early high-dose caffeine citrate for extremely preterm infants:neonatal and neurodevelopmental outcomes.J Paediatr Child Health,2019,55:1451-1457.
[26] Ji D,Smith PB,Clark RH,et al.Wide variation in caffeine discontinuation timing in premature infants.J Perinatol,2020,40:288-293.
[27] Gentle SJ,Travers CP,Carlo WA.Caffeine controversies.Curre Opin Pediatr,2018,30:177-181.
[28] Abu-Shaweesh JM,Martin RJ.Caffeine use in the neonatal intensive care unit.Semin Fetal Neonatal Med,2017,22:342-347.
[29] Rhein LM,Dobson NR,Darnall RA,et al.Effects of caffeine on intermittent hypoxia in infants born prematurely:a randomized clinical trial.JAMA Pediatr,2014,168:250-257.
[30] Chung J,Tran Lopez K,Amendolia B,et al.Stopping caffeine in premature neonates:how long does it take for the level of caffeine to fall below the therapeutic range?.J Matern Fetal Neonatal Med,2020:551-555.
[31] Natarajan G,Botica ML,Thomas R,et al.Therapeutic drug monitoring for caffeine in preterm neonates:an unnecessary exercise?.Pediatrics,2007,119:936-940.
[32] He X,Qiu JC,Lu KY,et al.Therapy for Apnoea of Prematurity:A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.Adv Ther,2021,38:607-626.
[33] Gao XB,Zheng Y,Yang F,et al.Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity:A post‐marketing study to support paediatric labelling in China.Br J Clin Pharmacol,2021,87:1155-1164.
[34] Aranda JV,Beharry KD.Pharmacokinetics,pharmacodynamics and metabolism of caffeine in newborns.Semin Fetal Neonatal Med,2020,25:101183.
[35] Abduljalil K,Pan X,Pansari A,et al.Preterm Physiologically Based Pharmacokinetic Model.Part II:Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.Clin Pharmacokinet,2020,59:501-518.
[36] Verscheijden LFM,Koenderink JB,Johnson TN,et al.Physiologically-based pharmacokinetic models for children:Starting to reach maturation? Pharmacol Ther,2020,211:107541.
[37] Long JY,Guo HL,He X,et al.Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU:Dose Selection Conundrum,Therapeutic Drug Monitoring and Genetic Factors.Front Pharmacol,2021,12:681842.
[38] Saroha V,Patel RM.Caffeine for preterm infants:fixed standard dose,adjustments for age or high dose? Semin Fetal Neonatal Med,2020,25:101178.
[39] Abdel Wahed MA,Issa HM,Khafagy SM,et al.Effect of caffeine on superior mesenteric artery blood flow velocities in preterm neonates.J Matern Fetal Neonatal Med,2019,32:357-361.
[40] Puia-Dumitrescu M,Smith PB,Zhao J,et al.Dosing and Safety of Off-Label Use of Caffeine Citrate in Premature Infants.J Pediatr,2019,211:27-32.
[41] Brattström P,Russo C,Ley D,et al.High-versus low-dose caffeine in preterm infants:a systematic review and meta-analysis.Acta Paediatr,2019,108:401-410.
